OOIR: Observatory of International Research

Papers

(The H4-Index of Neurobiology of Disease is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs	162
Estrogen-related receptor gamma is a regulator of mitochondrial, autophagy, and immediate-early gene programs in spiny projection neurons: Relevance for transcriptional changes in Huntington disease	153
New perspectives on the role of biological factors in anorexia nervosa: Brain volume reduction or oxidative stress, which came first?	111
The predictive value of mBDNF for major adverse cardiovascular events in stable coronary artery disease patients with depressive symptoms: A single-center, 5-year follow-up study	97
Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease	95
The neoliberal leaning of the neuroscience discourse when it deals with mental health and learning disorders	89
Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy	88
Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner	85
Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer's disease	83
Stem cell therapy for central nervous system disorders: Metabolic interactions between transplanted cells and local microenvironments	83
Evoked resonant neural activity in subthalamic local field potentials reflects basal ganglia network dynamics	82
Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression	73
Gut-brain axis in the pathogenesis of sepsis-associated encephalopathy	73
Diagnostic and prognostic value of the RUNXOR/RUNX1 axis in multiple sclerosis	68
Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours	64
Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism	62
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition	61
Inflammation in dementia with Lewy bodies	60
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers	60
T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease	59
The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes	57
Amyloid beta peptides (Aβ) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model	54
Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy	54
CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice	54
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration	53

Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease	53
A novel role for the ADHD risk gene latrophilin-3 in learning and memory in Lphn3 knockout rats	52
The altered sensitivity of acute stress induced anxiety-related behaviors by modulating insular cortex-paraventricular thalamus-bed nucleus of the stria terminalis neural circuit	52
miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy	51
Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain	51
Sunitinib-mediated inhibition of STAT3 in skeletal muscle and spinal cord does not affect the disease in a mouse model of ALS	50
Early suppression of excitability in subcortical band heterotopia modifies epileptogenesis in rats	50
Epigenomic analysis of Alzheimer's disease brains reveals diminished CTCF binding on genes involved in synaptic organization	49
Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease	49
Neonatal stroke enhances interaction of microglia-derived extracellular vesicles with microglial cells	49
Alternative platelet activation pathways and their role in neurodegenerative diseases	49
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models	48
Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a mice	48
Potential clinical and biochemical markers for the prediction of drug-resistant epilepsy: A literature review	48
B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis	47
Neuronal hyperexcitability and ion channel dysfunction in CDKL5-deficiency patient iPSC-derived cortical organoids	47
Altered static and dynamic functional connectivity of the default mode network across epilepsy subtypes in children: A resting-state fMRI study	47
Corrigendum to “Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy” [Neurobiology	43
Corrigendum to “Isoflurane on brain inflammation” [Neurobiology of Disease, 62 (2014) Pages 365–371]	43
14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity	43
Increased propensity for infantile spasms and altered neocortical excitation-inhibition balance in a mouse model of down syndrome carrying human chromosome 21	43